JAK inhibitors are a class of medications designed to interfere with the activity of Janus kinase enzymes, which are key in driving the inflammatory process of RA. By blocking these enzymes, JAK inhibitors can help reduce inflammation and modify the disease’s progression. This action aims to alleviate pain, reduce joint swelling, and improve mobility for those struggling with RA.
